Veterinary (Pet) Therapeutic Antibody Target Discovery Services
The strong bond between humans and pets is fueling demand for advanced veterinary treatments similar to those for humans. Targeted antibody therapies are a promising area, but their success depends on discovering the right therapeutic target. Creative Biolabs specializes in this crucial first step, offering comprehensive target discovery services to speed up the creation of new veterinary medicines and meet this growing need for advanced pet healthcare.
Introduction
The landscape of animal health is rapidly evolving, with a growing emphasis on chronic and age-related diseases in pets, including cancer, inflammatory disorders, and autoimmune conditions. Monoclonal antibodies have emerged as a highly promising therapeutic modality, offering the potential for targeted treatments with fewer side effects. At Creative Biolabs, we specialize in navigating this complexity. Our dedicated team of scientists leverages a multi-omics approach, integrating genomics, transcriptomics, and proteomics and effective screening technologies to identify and validate the most promising therapeutic targets for a wide range of pet diseases. Ready to explore novel targets for your veterinary therapeutic pipeline?
Antibody Target Discovery Services
We offer a portfolio of target discovery services that can be tailored to meet the specific needs of your research program. By employing a range of sophisticated techniques, we can identify novel targets, validate their role in disease, and provide the crucial data needed to move your project forward with confidence.
Genomic Solution
Our genomic solutions uncover disease-associated genetic variations in companion animals through comprehensive DNA analysis. By comparing genomes of healthy and affected animals, we identify mutations and pathways driving disease. This enables precise discovery of novel antibody targets rooted in the genetic basis of pathology—especially for inherited or complex diseases—laying the foundation for rational therapeutic design tailored to veterinary medicine.
Transcriptomic Solution
Our transcriptomic services provide real-time insights into gene activity by analyzing RNA from disease tissues. This method highlights genes that are actively expressed or suppressed during disease progression, revealing dynamic targets for antibody therapies. It's particularly powerful for identifying drivers of inflammatory or autoimmune conditions in companion animals, where understanding molecular behavior is critical to effective intervention.
Proteomic Solution
Our proteomic platforms offer large-scale protein profiling from tissues and fluids, identifying disease-specific proteins and modifications. Since proteins are often the direct targets of antibody drugs, this approach enables accurate selection of actionable targets. By comparing proteomes between healthy and diseased animals, we pinpoint biomarkers and pathways suitable for therapeutic antibody development in veterinary applications.
In Silico Target Screening
We use advanced bioinformatics to integrate genomic, transcriptomic, and proteomic data for predictive target discovery. Our in silico screening identifies and ranks candidate targets based on disease relevance, druggability, and species specificity. This computational approach streamlines discovery by focusing lab resources on the most promising antibody targets, accelerating project timelines and reducing development risks in veterinary research.
High-Throughput Target Screening
Our high-throughput screening (HTS) platforms validate potential targets in relevant cellular models. By testing candidate proteins for functionality and antibody responsiveness, we ensure selected targets are not only disease-associated but also therapeutically actionable. HTS reduces risk and enhances confidence in moving forward with antibody development, providing a strong preclinical foundation for veterinary therapeutic projects.
Workflow: A Streamlined Path to Target Discovery
We have developed a systematic and efficient workflow to guide our clients from initial concept to a validated canine or feline therapeutic target, ensuring a seamless and collaborative process.
Fig.1 Pet Therapeutic Antibody Target Discovery Workflow. (Creative Biolabs Original)
Why Choose Us?
FAQs
Related Services
To support your entire therapeutic antibody development pipeline, Creative Biolabs also offers a range of related services:
Phage Display Pet Antibody Discovery
We utilize advanced phage display technologies to generate high-affinity antibodies against your validated target.
Single B-Cell Sorting Pet Antibody Discovery
Combine with antibody modification services to produce rare, high-performing antibodies directly from the immune system of your chosen species.
Hybridoma Pet Antibody Discovery
Leverage this classic and robust method for generating monoclonal antibodies, optimized for veterinary applications.
Veterinary Antigen Generation
We can produce high-quality recombinant proteins and other antigens required for immunization and antibody screening.
Pet Antibody Characterization
Our comprehensive characterization services will provide you with a deep understanding of your antibody's binding properties, kinetics, and functionality.
Pet Antibody Engineering
We can optimize your lead antibody candidates through processes like species-specific adaptation (e.g., caninization, felinization) and affinity maturation to enhance their therapeutic potential.
Partner with Creative Biolabs
The discovery of novel and effective therapeutic targets is the cornerstone of innovation in veterinary medicine. Creative Biolabs provides the specialized expertise, advanced technology, and collaborative partnership needed to navigate this critical first step in the development of next-generation antibody therapies for companion animals. By focusing exclusively on pet species and employing a powerful multi-omics approach, we are uniquely positioned to help you unlock new therapeutic possibilities and bring life-changing treatments to the animals that enrich our lives.
Ready to accelerate your pet therapeutic antibody program by accurate antibody target discovery? Contact us today to discuss your pet antibody target discovery project with one of our specialists.